MedPath

济南明鑫制药股份有限公司

Ownership
-
Established
2003-02-14
Employees
-
Market Cap
-
Website
http://www.mingxinpharm.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

19

NMPA:19

Drug Approvals

Sildenafil Citrate Tablets

Product Name
枸橼酸西地那非片
Approval Number
国药准字H20247028
Approval Date
Feb 6, 2024
NMPA

Vildagliptin Tablets

Product Name
维格列汀片
Approval Number
国药准字H20234624
Approval Date
Dec 13, 2023
NMPA

Omeprazole Enteric-coated Capsules

Product Name
奥美拉唑肠溶胶囊
Approval Number
国药准字H20084393
Approval Date
May 30, 2023
NMPA

Sildenafil Citrate Tablets

Product Name
枸橼酸西地那非片
Approval Number
国药准字H20223736
Approval Date
Oct 11, 2022
NMPA

Adenosine Disodium Triphosphate Tablets

Product Name
三磷酸腺苷二钠片
Approval Number
国药准字H20066143
Approval Date
Apr 7, 2021
NMPA

Pantoprazole sodium

Product Name
泮托拉唑钠
Approval Number
国药准字H20067105
Approval Date
Mar 19, 2021
NMPA

Nateglinide

Approval Number
国药准字H20060814
Approval Date
Feb 2, 2021
NMPA

Terbinafine Hydrochloride

Product Name
盐酸特比萘芬
Approval Number
国药准字H20063636
Approval Date
Oct 16, 2020
NMPA

Marine Tablets

Product Name
龙鑫甘
Approval Number
国药准字H20051827
Approval Date
Sep 10, 2019
NMPA

Inosine

Product Name
肌苷
Approval Number
国药准字H37020036
Approval Date
Sep 10, 2019
NMPA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.